Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ·Healthcare·Biotechnology
$23.28
-0.62%
Mkt Cap $2.89B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $113.06M | $129.50M | +14.55% | $0.03 | $0.13 | +333.33% | — | — |
| Q4 2025 Oct 28, 2025 | $110.79M | $99.22M | -10.45% | -$0.10 | $0.06 | +160.00% | — | — |
| Q3 2025 Aug 6, 2025 | $80.63M | $81.50M | +1.09% | -$0.18 | -$0.13 | +27.78% | — | — |
| Q2 2025 May 6, 2025 | $72.70M | $65.85M | -9.43% | -$0.21 | -$0.20 | +4.76% | — | — |
| Q1 2025 Feb 25, 2025 | $60.52M | $71.36M | +17.92% | -$0.28 | -$0.09 | +67.86% | — | — |
| Q4 2024 Nov 6, 2024 | $37.62M | $44.76M | +18.97% | -$0.42 | -$0.33 | +21.43% | — | — |
| Q3 2024 Aug 14, 2024 | $29.08M | $30.86M | +6.11% | -$0.48 | -$0.42 | +12.50% | — | — |
| Q2 2024 May 14, 2024 | $14.74M | $49.57M | +236.29% | -$0.60 | -$0.32 | +46.67% | — | — |
| Q1 2024 Feb 27, 2024 | $11.34M | $13.53M | +19.28% | -$0.65 | -$0.72 | -10.77% | — | — |
| Q4 2023 Nov 3, 2023 | $11.57M | $38.11M | +229.38% | -$0.90 | -$0.73 | +18.89% | — | — |
| Q3 2023 Aug 8, 2023 | $4.60M | $5.19M | +12.83% | -$1.22 | -$1.16 | +4.92% | — | — |
| Q2 2023 May 9, 2023 | $3.14M | $2.78M | -11.43% | -$1.30 | -$1.31 | -0.77% | — | — |
| Q1 2023 Feb 28, 2023 | $2.20M | $2.96M | +34.44% | -$1.37 | -$1.18 | +13.87% | — | — |
| Q4 2022 Nov 8, 2022 | $614.29K | $725.00K | +18.02% | -$1.54 | -$1.89 | -22.73% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$1.38 | -$1.31 | +5.07% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$1.42 | -$1.27 | +10.56% | — | — |
| Q1 2022 Feb 22, 2022 | — | — | — | -$1.41 | -$1.42 | -0.71% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$1.09 | -$1.14 | -4.59% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$0.91 | -$0.84 | +7.69% | — | — |
| Q2 2021 May 4, 2021 | — | — | — | -$0.96 | -$0.76 | +20.83% | — | — |